Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors

• Main Authors: Rita Nade (Author), Esther Tannoury (Author), Tamina Rizk (Author), Hady Ghanem (Author)
• פורמט: ספר
• יצא לאור: University of São Paulo, 2021-04-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Immune-mediated encephalitis as an adverse event due to checkpoint inhibitors is very rare. We describe herein the case of a 38-year-old woman with metastatic triple-negative breast cancer who developed seizures and somnolence twelve days after receiving the first dose of Atezolizumab. Work up ruled...